陳新
下載導師簡歷CV
Section 1: Personal Particulars
陳新
Xin Chen
Professor
65581387
xchen@um.edu.mo
Taipa
University of Macau
UMAC-SKL of Quality Research in Chinese Medicine
Distinguished Professor, director
Research Project provided for Macao Youth Scholars Program:
靶向TNFR2 新型腫瘤診療一體化分子探針的研發
Research and development of TNFR2-targeting molecular imaging probes for disgnosis and therapy of cancer
1001 基础医学
Section 2: Research Interests and Grants
2023-2025: CI. Design and development of new tumor immunomodulators based on scutellarin molecular skeleton. Guangdong Bureau of Science and Technology. CNY 1,000,000 ($140,000 USD).
2024-2024: PI. CPG2024-00031-ICMS. Role of TNFR2 In the Expansion of Treg Cells Induced by HIV Envelope Glycoprotein gp120. MOP350,000 ($43,437).
2023-2026: PI. 0007/2022/AKP. Research and development of TNFR2-targeting molecular imaging probes for diagnosis and therapy of cancer. MOP 12,000,000 ($1.5 million USD)
2023-2023: PI. CPG2023-00025-ICMS. Effect of miR-125b-5p on TNFR2 expression by tumor cells and on the efficacy of cancer immunotherapy. MOP350,000 ($1.5 million USD)
2023-2024: PI. MYRG2022-00260-ICMS. University of Macau Research Committee Multiple Year Research Grant. The role of TNFR2 signal in the function of CD8 cytotoxic T lymphocytes (CTLs). MOP 608,000.00 ($75,224.74 USD).
2021-2024: PI. 0099/2021/A2. Macau Science and Technology Development Fund. Small Molecule TNFR2 Inhibitors as Novel Anti-tumor Immunotherapy Drug Candidates. MOP 2,400,000 ($238,787.00 USD)
2021-2024: PI. Development of anti-human TNFR2 single domain antibody and its application in tumor immunotherapy. Research Institute of Tsinghua, Pearl River Delta. CNY 2,600,000 ($407,000 USD)
2024-2024: PI. CPG2024-00031-ICMS. Role of TNFR2 In the Expansion of Treg Cells Induced by HIV Envelope Glycoprotein gp120. MOP350,000 ($43,437).
2023-2026: PI. 0007/2022/AKP. Research and development of TNFR2-targeting molecular imaging probes for diagnosis and therapy of cancer. MOP 12,000,000 ($1.5 million USD)
2023-2023: PI. CPG2023-00025-ICMS. Effect of miR-125b-5p on TNFR2 expression by tumor cells and on the efficacy of cancer immunotherapy. MOP350,000 ($1.5 million USD)
2023-2024: PI. MYRG2022-00260-ICMS. University of Macau Research Committee Multiple Year Research Grant. The role of TNFR2 signal in the function of CD8 cytotoxic T lymphocytes (CTLs). MOP 608,000.00 ($75,224.74 USD).
2021-2024: PI. 0099/2021/A2. Macau Science and Technology Development Fund. Small Molecule TNFR2 Inhibitors as Novel Anti-tumor Immunotherapy Drug Candidates. MOP 2,400,000 ($238,787.00 USD)
2021-2024: PI. Development of anti-human TNFR2 single domain antibody and its application in tumor immunotherapy. Research Institute of Tsinghua, Pearl River Delta. CNY 2,600,000 ($407,000 USD)